Characterization of PIK3CA mutations in lobular breast cancer

被引:0
|
作者
Desmedt, C.
Metzger
Fumagalli, D.
Brown, D.
Singhal, S.
Vincent, D.
Adnet, P-Y
Smeets, D.
Berthed, F.
Galant, C.
Salgado, R.
Veys, I.
Saini, K.
Pruneri, G.
Krop, I.
Winer, E.
Michiels, S.
Piccart, M.
Lambrechts, D.
Larsimont, D.
Viale, G.
Sotiriou, C.
机构
[1] Inst Jules Bordet, B-1000 Brussels, Belgium
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] VIB, Vesalius Res Ctr, Leuven, Belgium
[4] Inst J Paoli I Calmettes, F-13009 Marseille, France
[5] Catholic Univ Louvain, B-1200 Brussels, Belgium
[6] Univ Milan, European Inst Oncol, Milan, Italy
关键词
D O I
10.1158/0008-5472.SABCS12-P3-05-03
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3-05-03
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Oncogenic PIK3CA mutations in lobular breast cancer progression
    Christgen, Matthias
    Noskowicz, Monika
    Schipper, Elisa
    Christgen, Henriette
    Heil, Charlotte
    Krech, Till
    Laenger, Florian
    Kreipe, Hans
    Lehmann, Ulrich
    [J]. GENES CHROMOSOMES & CANCER, 2013, 52 (01): : 69 - 80
  • [2] PIK3CA mutations in breast cancer: A Tunisian series
    Ben Rekaya, Mariem
    Sassi, Farah
    Saied, Essya
    Kacem, Linda Bel Haj
    Mansouri, Nada
    Zarrouk, Sinda
    Azouz, Saifeddine
    Rammeh, Soumaya
    [J]. PLOS ONE, 2023, 18 (05):
  • [3] Analysis of PIK3CA Mutations in Breast Cancer Subtypes
    Arsenic, Ruza
    Lehmann, Annika
    Budczies, Jan
    Koch, Ines
    Prinzler, Judith
    Kleine-Tebbe, Anke
    Schewe, Christiane
    Loibl, Sibylle
    Dietel, Manfred
    Denkert, Carsten
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (01) : 50 - 56
  • [4] Biphasic Papillary and Lobular Breast Carcinoma With PIK3CA and IDH1 Mutations
    Ang, Daphne
    VanSandt, Amanda M.
    Beadling, Carol
    Warrick, Andrea
    West, Robert B.
    Corless, Christopher L.
    Troxell, Megan L.
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 2012, 21 (04) : 221 - 224
  • [5] Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
    Chen, Li
    Yang, Liu
    Yao, Ling
    Kuang, Xia-Ying
    Zuo, Wen-Jia
    Li, Shan
    Qiao, Feng
    Liu, Yi-Rong
    Cao, Zhi-Gang
    Zhou, Shu-Ling
    Zhou, Xiao-Yan
    Yang, Wen-Tao
    Shi, Jin-Xiu
    Huang, Wei
    Hu, Xin
    Shao, Zhi-Ming
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [6] PIK3CA mutations in breast cancer are associated with poor outcome
    Li, SY
    Rong, MN
    Grieu, F
    Iacopetta, B
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 96 (01) : 91 - 95
  • [7] PIK3CA mutations in endocrine-resistant breast cancer
    Schagerholm, C.
    Robertson, S.
    Holm, B.
    Awier, H.
    Toosi, H.
    Sifakis, E.
    Hartman, J.
    [J]. VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S42 - S43
  • [8] Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
    Li Chen
    Liu Yang
    Ling Yao
    Xia-Ying Kuang
    Wen-Jia Zuo
    Shan Li
    Feng Qiao
    Yi-Rong Liu
    Zhi-Gang Cao
    Shu-Ling Zhou
    Xiao-Yan Zhou
    Wen-Tao Yang
    Jin-Xiu Shi
    Wei Huang
    Xin Hu
    Zhi-Ming Shao
    [J]. Nature Communications, 9
  • [9] Frequency and spectrum of PIK3CA somatic mutations in breast cancer
    Olga Martínez-Sáez
    Nuria Chic
    Tomás Pascual
    Barbara Adamo
    Maria Vidal
    Blanca González-Farré
    Esther Sanfeliu
    Francesco Schettini
    Benedetta Conte
    Fara Brasó-Maristany
    Adela Rodríguez
    Débora Martínez
    Patricia Galván
    Ana Belén Rodríguez
    Antonio Martinez
    Montserrat Muñoz
    Aleix Prat
    [J]. Breast Cancer Research, 22
  • [10] PIK3CA mutations in endocrine-resistant breast cancer
    Schagerholm, Caroline
    Robertson, Stephanie
    Toosi, Hosein
    Sifakis, Emmanouil G.
    Hartman, Johan
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):